Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a potential advance in weight loss . Early clinical trials have demonstrated impressive https://adrianavjbi072723.jiliblog.com/100167315/retatrutide-in-australia-a-potential-breakthrough-for-obesity-management